top of page

Goals

We aim to develop and commercialize cutting-edge treatments for autoimmune diseases.

We are looking for investors and partners to co-develop new

aptamer therapeutics for human autoimmune diseases including rheumatoid arthritis, Graves' disease, lupus and type 1 diabetes.

Hjerne

© 2023 by Aptol Pharma. Proudly created with Wix.com

bottom of page